3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Prostatic Neoplasms
5
Lung Neoplasms
5
Endometrial Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Meningioma
1
Interventions
Dexamethasone
116
daratumumab
68
Lenalidomide
67
Bortezomib
55
pomalidomide
45
carfilzomib
40
Cyclophosphamide
33
Calcium Dobesilate
32
Specimen Handling
30
Biopsy
28
Magnetic Resonance Spectroscopy
25
isatuximab
20
belantamab mafodotin
20
talquetamab
17
iberdomide
17
fludarabine
17
Melphalan
15
dexamethasone acetate
14
dexamethasone 21-phosphate
14
auricularum
14
fludarabine phosphate
11
selinexor
10
elotuzumab
10
tocilizumab
9
X-Rays
8
Nivolumab
8
trametinib
7
Sirolimus
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Observation
×
90 days
×
Clear all
No trials found.